Propulsion of Small Lymphocytic Lymphoma Clinical Trial
The global Small Lymphocytic Lymphoma Treatment market has significantly grown over the past few years and is expected to register rapid growth. Revenue...
Source: globenewswire.com
📰 Evive Biotech News
Evive Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evive Biotech. Real-time updates on events, politics, business and more.
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery
/PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and Evive Biotech, a global...
United Kingdom Jingsong Wang Prnewswire Nona Biosciences Nona Biosciences Simon Li Yifan Pharmaceutical Co Ltd
Source: prnewswire.com
Cocaine-like price hike: China's new cancer drug is approved in the US but will cost 30 times more
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Source: scmp.com
FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.
Drug Administration Evive Biotech Breast Cancer Alignant Breast Neoplasm Alignant Neoplasia Us Food And Drug Administration
Source: medscape.com
Aurobindo Pharma: Aurobindo Unit Gets Usfda Nod For Ryzeneuta | Hyderabad News
Hyderabad: Pharma major Aurobindo Pharma on Wednesday said the US Food & Drug Administration (USFDA) has approved Ryzneuta (Efbemalenograstim alfa inj.
Andhra Pradesh Uttar Pradesh Ramkuber Singh Ashish Anvekar Ryzneuta Efbemalenograstim Aurobindo Pharma
Source: indiatimes.com